Saik Andrew — SEC Form 4 filings
SEC reporting owner CIK 1616284. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-06-26 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 27,669 shares, $261,587 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 11,139 shares @ $9.94 ($110,693) in ARVINAS, INC., filed 2026-05-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARVINAS, INC. (ARVN) | Chief Financial Officer | 8 | — | 4 legs · 27,669 sh · $261,587 | 8 |
| Milestone Pharmaceuticals Inc. (MIST) | Director | 4 | — | — | 4 |
Form 4 filings — Saik Andrew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | ARVINAS, INC. (ARVN) | Sale (S): 5,696 @ $8.16 | EDGAR |
| 2026-06-12 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 77,000 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | ARVINAS, INC. (ARVN) | Sale (S): 11,139 @ $9.94 | EDGAR |
| 2026-03-02 | 4 | ARVINAS, INC. (ARVN) | Grant/award (A): 45,000 @ $0 · Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | ARVINAS, INC. (ARVN) | Sale (S): 5,134 @ $11.89 | EDGAR |
| 2025-06-24 | 4 | ARVINAS, INC. (ARVN) | Sale (S): 5,700 @ $7.61 | EDGAR |
| 2025-06-12 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | ARVINAS, INC. (ARVN) | Grant/award (A): 59,600 @ $0 · Grant/award (A): 91,000 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | ARVINAS, INC. (ARVN) | Grant/award (A): 49,092 @ $0 · Grant/award (A): 74,960 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | Milestone Pharmaceuticals Inc. (MIST) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | ARVINAS, INC. (ARVN) | Grant/award (A): 61,409 @ $0 · Grant/award (A): 94,418 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1616284 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →